ASHM offers a range of face-to-face, webinar and online training courses specifically designed for health professionals and any other specific workforces that require hepatitis C education and training.  

ASHM tailors training courses to address the specific needs of the audience and epidemiology and service practicalities of the locality in which it is delivered. We use local experts to deliver the training wherever possible.   

We can develop and tailor courses to meet your specific needs. Please contact ASHM​ if you would like to discuss customised training for your workforce. 

Face-to-face training

Needle and Syringe Program (NSP) Frontline Workers have a crucial and unique role to play in the elimination of hep C in Australia.  This comprehensive education program aimed at those working at the frontline of primary, secondary and pharmacy NSPs aims to provide participants with the confidence to initiate conversations around hep C in the NSP and provide appropriate referral to health services for hep C testing and treatment.

The program includes an online learning module followed by an interactive workshop enabling collaboration amongst participants through case study discussions, and self and group reflection activities around addressing challenges to providing hep C education in the NSP.

After completing all components of this course, participants will have an understanding of hep C prevention and natural history, how to start the conversation around hep C, hep C testing and liver disease assessment, treatment options for hep C, and how to continue engagement with people in the NSP around hep C.  

Duration:  1.5 hour online learning module + 3 hour face-to-face workshop.

A comprehensive education program for medical practitioners wishing to prescribe HCV treatment independently. The program includes a predisposing case study activity, online learning module, full day face-face workshop and reinforcing activity. Through case study discussions, the interactive workshop covers diagnosis and assessment, treatment decisions, monitoring during and post-treatment, and special issues such as; resistance, treating HCV in renal patients, HIV-HCV co-infection, HBV reactivation and risk of HCC during /after DAA therapy for HCV.  

Duration:  2.5 hour online learning Module (Curing Hepatitis C in Primary Care – eLearning) + 5 hour face-face workshop 

CPD:  Active Learning Module: 40 Category 1 RACGP QI & CPD points.

A comprehensive education program for practitioners working in drug and alcohol settings or with people who inject drugs. The program is designed to provide participants with the confidence and clinical decision-making skills to be able to increase testing and linkage to HCV care in their practice, and to prescribe DAA therapy either independently or in consultation with a specialist.  

The program includes an online learning module and highly interactive workshop enabling practical and collaborative application of knowledge through case study discussions. 

To enable course participants to demonstrate their competency in management and treatment of hepatitis C.  

Course participants, who successfully complete all components of this course including the online assessment, will have the confidence, knowledge and clinical decision-making skills to be able to prescribe DAAs for the treatment of HCV infection, either independently or in collaboration with a specialist as appropriate to enable course participants to demonstrate their competency in management and treatment of hepatitis C. 

Duration:  2.5 hour online learning module (Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program – eLearning) + 6 hour face-face workshop 

CPD:  Active Learning Module: 40 Category 1 RACGP QI & CPD points 

 

An introductory course for GPS, nurses and other primary care based practitioners covering; HCV epidemiology, identifying priority populations for testing, interpreting test results and diagnosis, pre-treatment assessment, evaluating liver fibrosis, treatment for hepatitis C, mechanisms for prescribing (either independently or in consultation with a specialist), monitoring and follow-up.  

Duration:  2.5 hours face-face workshop 

CPD:  4 Category 2 RACGP QI & CPD point.

 

An introductory course for practitioners working drug and alcohol settings or with people who inject drugs covering epidemiology, testing and diagnosis, fibrosis assessment and treatment of hepatitis C according to recommended guidelines. The course is open to all AOD staff including; GPs, addictions specialists, nurses and allied health. 

Duration:  2.5 hours face-face workshop 

CPD:  4 Category 2 RACGP QI & CPD points 

 

This 2 day face to face course is designed for nurses working in Primary Health Care settings including General Practice, Corrective Services, Drug and Alcohol services, mental health services.  The program content is delivered through presentations and case discussions that introduce the epidemiology and natural history of hepatitis C, population groups to consider for screening, testing and the nurses role in case finding, assessment for treatment, fibrosis assessment, advanced liver disease, stigma and discrimination. 

Duration:  2 days face-face workshop 

CPD: 13 hours CPD (APNA and ACN endorsed activity) Certificate of attendance provided .

 

Online training

This online learning module consists of 4 individual modules covering: prevention and starting the conversation around hep C; hep C testing; treatment for hep C; and ongoing engagement with people in the NSP. These modules are designed for those working at the frontline of the NSP, with the goal of increasing ability and confidence to have conversations around hep C in the NSP and to link people to appropriate health services.  

Duration:  1.5 hours  

Link:https://lms.ashm.org.au/enrol/index.php?id=1202

 

This online learning module consists of 4 individual modules covering; HCV epidemiology, prevention and natural history; HCV testing and liver disease staging; Treatment options for HCV; and Monitoring, adherence and post-treatment follow-up. These modules are designed for medical practitioners working in drug and alcohol settings or with people who inject drugs.  

Duration:  2 hours  

Link:https://lms.ashm.org.au/course/explore_courses.php?categoryid=91

 

Part 1 of this online learning consists of 4 individual modules covering; HCV epidemiology, prevention and natural history; HCV testing and liver disease staging; Treatment options for HCV; and Monitoring, adherence and post-treatment follow-up. These modules are designed for medical practitioners, nurses and other health care professionals working in primary care settings.  

Duration:  2.5 hours 

Part 2 of the eLearning is a case-based Refresher Module that aims to reinforce the assessment, management, treatment selection and monitoring for people with chronic  hepatitis C.    

Duration: 30 mins 

 

Developed by AIVL, the ‘Normal Day’ podcast series and resources features conversations between healthcare professionals and people who use drugs on the challenges and misunderstandings that sometimes occur within the clinical relationship. The six-part series includes interviews with GPs, pharmacists, researchers, emergency room physicians and GP receptionists who provide unique insights and rarely heard perspectives.  

Duration: 1.5 hours 

Link: https://lms.ashm.org.au/course/explore_courses.php?categoryid=91

 

 

Webinars

ASHM is experienced in the delivery of webinars and provides opportunities for health professionals to access ASHM and partner organisation training remotely. Existing webinars cover clinical skill development, health promotion and research dissemination. Participants can register and ‘attend’ online to enable them to interact with presenters or can access recordings at any time for convenience.    

Find a webinar happening soon or access a webinar recording.